Noninfective drug-related pneumonitis (DRP) is a well-known adverse effect of several drugs: clinical manifestations have mostly an acute/subacute onset and vary from mild to life-threatening. Several DRP cases have been described in patients receiving anti-tumor necrosis factor α, rituximab, and tocilizumab.1,2 To date, only 4 reports of vedolizumab-related pneumonitis have been presented.

Drug-related pneumonitis in patients receiving Vedolizumab therapy for Inflammatory Bowel Disease / D. Pugliese, G. Privitera, T. Schepis, L. Larosa, S. Onali, F. Scaldaferri, A. Gasbarrini, F. Caprioli, A. Armuzzi. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - (2021). [Epub ahead of print] [10.1016/j.cgh.2021.08.041]

Drug-related pneumonitis in patients receiving Vedolizumab therapy for Inflammatory Bowel Disease

F. Caprioli;
2021

Abstract

Noninfective drug-related pneumonitis (DRP) is a well-known adverse effect of several drugs: clinical manifestations have mostly an acute/subacute onset and vary from mild to life-threatening. Several DRP cases have been described in patients receiving anti-tumor necrosis factor α, rituximab, and tocilizumab.1,2 To date, only 4 reports of vedolizumab-related pneumonitis have been presented.
Settore MED/12 - Gastroenterologia
31-ago-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1542356521009216-main.pdf

embargo fino al 31/08/2022

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 622.45 kB
Formato Adobe PDF
622.45 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/867541
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact